These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9597248)

  • 21. In vitro activity of teicoplanin against gram-positive cocci.
    Allouch P; Pina P; Chaplain C; Delarbre JM; Geffroy F; Grasmick CP; Marcolin M; Morel A; Pangon B; Rio Y; Sédaillan A
    Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systematic review of antimicrobial resistance among Gram positive cocci in hospitals in Colombia].
    Espinosa CJ; Cortés JA; Castillo JS; Leal AL
    Biomedica; 2011 Mar; 31(1):27-34. PubMed ID: 22159481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of vancomycin against recently isolated nosocomial gram-positive cocci.
    Maccanti O; Bonadio M
    Drugs Exp Clin Res; 1992; 18(7):295-7. PubMed ID: 1295722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of multiply resistant cocci: do international comparisons help?
    Harbarth S; Albrich W; Goldmann DA; Huebner J
    Lancet Infect Dis; 2001 Nov; 1(4):251-61. PubMed ID: 11871512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Sugiyama T; Toyoshima S; Kato J; Watanabe N; Kaku M; Kanemitsu K; Kunishima H; Kawaguchi H; Okada J; Shimoyama N; Igari J; Oguri T; Kaimori M; Watanabe K; Kobayashi Y; Uchida H; Katayama Y; Sugimoto K; Tashiro H; Kanno H; Yasujima M; Itoh K; Suwabe A; Obata R; Okada M; Kobayashi S; Tsuzimura M; Itoh A; Sumitomo M; Taminato T; Negayama K; Baba H; Makino H; Murase M; Miyamoto H; Minakuchi K; Ishigo S; Takii M; Horii T; Ono J; Takata T; Yamanaka K; Hamazaki N; Tsutsui T; Okabe H; Tatewaki K; Moro K; Hiramatsu K; Saikawa T; Ichiyama S; Nagasawa Z; Aoki Y; Matsushima T; Niki Y; Hirakata Y; Kohno S; Kuwabara M; Nakagawa K; Kageoka T; Hongo T; Yamane N
    Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
    Zhang FF; Zhao CJ; Wang ZW; Liu WY; Yan W; Peng QS; Jiang S; Guo Y; Liu JB; Chen HB; Li HN; Wang Q; Wang H
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):474-9. PubMed ID: 24059993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Consensus on antimicrobial sensitivity tests in gram-positive cocci. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Predari SC; Corso A; Lopardo H; Casellas JM; Bantar C; Couto E; Galas M; Goldberg M; Gutkind G; Kovensky Pupko J; Marín M; Nicola F; Pasterán F; Radice M; Soloaga R
    Rev Argent Microbiol; 2003; 35(1):29-40. PubMed ID: 12833678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
    Anderegg TR; Sader HS; Fritsche TR; Ross JE; Jones RN
    Int J Antimicrob Agents; 2005 Jul; 26(1):13-21. PubMed ID: 15967640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci.
    Hong SG; Moland ES; Wickman PA; Black JA; Hossain A; Hanson ND; Thomson KS
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1512-4. PubMed ID: 17220419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Emerging infectious and drug-resistant diseases--vancomycin resistant gram-positive cocci].
    Hanaki H; Hiramatsu K
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2075-80. PubMed ID: 9480313
    [No Abstract]   [Full Text] [Related]  

  • 32. [An antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2009].
    Sun HL; Wang H; Chen MJ; Liu YM; Hu ZD; Liao K; Chu YZ; Lei JE; Zhang B; Yu YS; Hu BJ; Sun ZY; Zhang Z; He QY
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):735-40. PubMed ID: 21092441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ziracin, a novel oligosaccharide antibiotic.
    Ganguly AK
    J Antibiot (Tokyo); 2000 Oct; 53(10):1038-44. PubMed ID: 11132948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linezolid in vitro: mechanism and antibacterial spectrum.
    Livermore DM
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii9-16. PubMed ID: 12730138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycopeptide-resistant Gemella haemolysans from blood.
    Reed C; Efstratiou A; Morrison D; Woodford N
    Lancet; 1993 Oct; 342(8876):927-8. PubMed ID: 8105186
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
    Rubinstein E; Bompart F
    J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New drugs for Gram-positive uropathogens.
    Wagenlehner FM; Naber KG
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S39-43. PubMed ID: 15364305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection].
    Yang QW; Wang H; Sun HL; Xu YC; Xie XL; Chen MJ
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):220-4. PubMed ID: 19576091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.